サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1790326

小児糖尿病管理の市場規模、シェア、動向分析レポート：製品別、技術別、最終用途別、地域別、セグメント予測、2025年～2033年

Pediatric Diabetes Management Market Size, Share & Trends Analysis Report By Product (Insulin Pump, Insulin Pen), By Technology (Connected, Non-Connected), By End Use (Homecare, Pediatric Clinics), By Region, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
小児糖尿病管理の市場規模、シェア、動向分析レポート：製品別、技術別、最終用途別、地域別、セグメント予測、2025年～2033年
出版日: 2025年07月01日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

小児糖尿病管理市場の概要

世界の小児糖尿病管理市場規模は2024年に55億9,000万米ドルと推定され、2033年には131億1,000万米ドルに達すると予測され、2025～2033年のCAGRは9.96%で成長すると予測されます。同市場の成長は、小児や青少年の間で糖尿病、特に1型糖尿病の世界の有病率が上昇し、効果的なモニタリングや治療ソリューションに対する需要が大幅に高まっていることに起因しています。

血糖モニタリング（BGM）、持続グルコースモニタリング（CGM）、インスリン送達システムの技術的進歩により、精度、利便性、コンプライアンスが向上し、小児の使用に適しています。世界的には、1型糖尿病は依然として小児に最も多い病型であるが、小児肥満の増加、座りがちなライフスタイル、食生活の乱れにより、低年齢層における2型糖尿病の診断が大幅に増加しています。国際糖尿病連合によると、2022年には20歳の約152万人が糖尿病に罹患するといいます。このような糖尿病有病率の高さは、常時モニタリングと長期的な疾病管理に対する需要を高め、小児に焦点を当てた糖尿病ケアソリューションの需要に寄与しています。小児患者グループの糖尿病に対処するための規制支援やイニシアチブの増加は、市場の成長をさらに促進します。

糖尿病管理機器の技術的進歩は、快適性、使いやすさ、リアルタイム洞察が疾患アドヒアランスに不可欠であることから、市場成長に大きく影響しています。小児や青少年に特化した、コンパクトで低侵襲、使いやすい機器の開発に投資する企業が増えています。チューブレスインスリンポンプ、センサ寿命が延長された持続グルコースモニター（CGM）、スマートフォン接続システムなどの革新的技術により、患者のコンプライアンスと保護者のモニタリングが向上しています。これらの機器は、インスリン投与を自動化し、予測アラートを生成することで、低血糖や高血糖のリスクを最小限に抑え、幼児と介護者の両方の負担を軽減します。

さらに、市場各社は製品の小型化など、小児に特化した設計機能の投入に注力しており、これが採用拡大にさらに貢献しています。例えば、2023年7月、Tandem Diabetes Careの小型サイズのインスリンポンプTandem Mobiは、iPhoneアプリで制御可能でCGMと互換性があり、小児（6歳以上）と成人向けにFDAの認可を取得しました。t：slim X2の半分の大きさで、Control IQオートメーションを統合し、より短いチューブとリモート更新を特徴とします。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 小児糖尿病管理市場の変数、動向、範囲

  • 市場系統の展望
    • 補助市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 小児糖尿病管理市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 小児糖尿病管理市場：製品別、推定・動向分析

  • セグメントダッシュボード
  • 小児糖尿病管理市場：製品変動分析と市場シェア、2024年と2033年
  • 血糖値モニター（BGM）
  • 持続血糖モニター（CGM）
  • インスリンポンプ
  • インスリンペン
  • インスリン注射器

第5章 小児糖尿病管理市場：技術別、推定・動向分析

  • セグメントダッシュボード
  • 小児糖尿病管理市場：技術変動分析と市場シェア、2024年と2033年
  • コネクテッド機器
  • 非コネクテッド機器

第6章 小児糖尿病管理市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 小児糖尿病管理市場：最終用途変動分析と市場シェア、2024年と2033年
  • 病院
    • 総合病院
    • 小児病院
  • 在宅医療
  • 小児科クリニック

第7章 小児糖尿病管理市場：製品、技術、最終用途による地域別、推定・動向分析

  • 地域展望
  • 小児糖尿病管理市場：地域変動分析と市場シェア、2024年と2033年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 市場参入企業の分類
  • 主要企業プロファイル
    • Medtronic
    • Dexcom
    • Abbott
    • Tandem Diabetes Care
    • Insulet Corporation
    • Novo Nordisk
    • Sanofi
    • Eli Lilly and Company
    • Roche Diabetes Care
    • Ascensia Diabetes Care
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global pediatric diabetes management market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 6 North America pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 10 U.S. pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 13 Canada pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 16 Mexico pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 19 Europe pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 23 UK pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 26 Germany pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 29 France pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 30 France pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 32 Italy pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 35 Spain pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 38 Denmark pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Sweden pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 44 Norway pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 51 China pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 52 China pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 53 China pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 54 Japan pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Japan pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 57 India pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 58 India pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 59 India pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 60 South Korea pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 62 South Korea pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 63 Australia pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Australia pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Thailand pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Thailand pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 69 Latin America pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 72 Latin America pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 73 Brazil pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 75 Brazil pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 76 Argentina pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 78 Argentina pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 79 MEA pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 82 MEA pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 83 South Africa pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 89 UAE pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 91 UAE pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Pediatric diabetes management market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Pediatric diabetes management market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Blood glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Continuous glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Insulin pumps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Insulin pens market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Insulin syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Non-connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 General hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Children hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Homecare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Pediatric clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Pediatric diabetes management market: Regional key takeaways (USD Million)
  • Fig. 26 Pediatric diabetes management market: Regional outlook, 2023 & 2033 (USD Million)
  • Fig. 27 North America pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Canada pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Mexico pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Europe pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 UK pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Germany pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 France pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Spain pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Italy pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Sweden pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Norway pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Denmark pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Asia Pacific pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 China pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Japan pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 India pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 South Korea pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Australia pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Thailand pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Latin America pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Brazil pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Argentina pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Middle East and Africa pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 South Africa pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Saudi Arabia pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 UAE pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Kuwait pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 List of key emerging companies
  • Fig. 56 Company market share analysis, 2024
  • Fig. 57 Market differentiators
  • Fig. 58 Competitive dashboard analysis
  • Fig. 59 Regional network map
目次
Product Code: GVR-4-68040-651-8

Pediatric Diabetes Market Summary

The global pediatric diabetes management market size was estimated at USD 5.59 billion in 2024 and is projected to reach USD 13.11 billion by 2033, growing at a CAGR of 9.96% from 2025 to 2033. The growth of the market is attributed to the rising global prevalence of diabetes, particularly Type 1, among children and adolescents, which has significantly increased the demand for effective monitoring and treatment solutions.

Technological advancements in blood glucose monitoring (BGM), continuous glucose monitoring (CGM), and insulin delivery systems have improved accuracy, convenience, and compliance, making them more suitable for pediatric use. Globally, type 1 diabetes remains the most common form in children, but the rising incidence of childhood obesity, sedentary lifestyles, and poor dietary habits has led to a significant rise in type 2 diabetes diagnoses in younger age groups. According to the International Diabetes Federation, around 1.52 million people aged 20 years had diabetes in 2022. This high prevalence of diabetes is increasing demand for constant monitoring and long-term disease management, thereby contributing to demand for pediatric-focused diabetes care solutions. The increasing regulatory support and initiatives to address diabetes in pediatric patient groups further fuel the market growth.

Technological advancements in diabetes management devices have significantly influenced the market growth as comfort, usability, and real-time insights are crucial for disease adherence. Companies are increasingly investing in the development of compact, minimally invasive, and user-friendly devices that cater specifically to children and adolescents. Innovations such as tubeless insulin pumps, continuous glucose monitors (CGMs) with extended sensor life, and smartphone-connected systems have improved patient compliance and parental monitoring. These devices reduce the burden on both children and caregivers by automating insulin dosing and generating predictive alerts, minimizing the risks of hypoglycemia or hyperglycemia.

Additionally, market players are focusing on launching pediatric-specific design features, such as miniaturization of products, further contributing to their increasing adoption. For instance, in July 2023, Tandem Diabetes Care's miniature-sized insulin pump, Tandem Mobi, controllable via iPhone app and compatible with CGM, got FDA clearance for children (>=6 years) and adults. Half the size of t : slim X2, it integrates Control IQ automation, features shorter tubing, and remote updates.

Global Pediatric Diabetes Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pediatric diabetes management market report on the basis of product, technology, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood Glucose Monitors (BGM)
  • Continuous Glucose Monitors (CGM)
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Connected Devices
  • Non-connected Devices
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
    • General Hospitals
    • Children Hospitals
  • Homecare
  • Pediatric Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased database.
  • 1.5. GVR's internal database
  • 1.6. Secondary sources
  • 1.7. Third Party Perspective
  • 1.8. Primary research
  • 1.9. Details of primary research
  • 1.10. Information or Data Analysis
  • 1.11. Data analysis models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity flow analysis (Model 1)
  • 1.15. Approach 1: Commodity flow approach
  • 1.16. Volume price analysis (Model 2)
  • 1.17. Approach 2: Volume price analysis
  • 1.18. List of Secondary Sources
  • 1.19. List of Primary Sources
  • 1.20. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pediatric Diabetes Management Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of diabetes in children and adolescents
      • 3.2.1.2. Technological advancements in diabetes management devices
      • 3.2.1.3. Increasing awareness and early diagnosis
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of certain diabetes management devices
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising preference toward advanced diabetes management devices
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Caregiver burden and patient education challenges
  • 3.3. Pediatric Diabetes Management Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Pediatric Diabetes Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pediatric Diabetes Management Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Blood Glucose Monitors (BGM)
    • 4.3.1. Blood Glucose Monitors (BGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Continuous Glucose Monitors (CGM)
    • 4.4.1. Continuous Glucose Monitors (CGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Insulin Pumps
    • 4.5.1. Insulin Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Insulin Pens
    • 4.6.1. Insulin Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Insulin Syringes
    • 4.7.1. Insulin Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pediatric Diabetes Management Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pediatric Diabetes Management Market: Technology Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Connected Devices
    • 5.3.1. Connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Non-connected Devices
    • 5.4.1. Non-connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pediatric Diabetes Management Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pediatric Diabetes Management Market: End-use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. General Hospitals
      • 6.3.2.1. General Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Children Hospitals
      • 6.3.3.1. Children Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Homecare
    • 6.4.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pediatric Clinics
    • 6.5.1. Pediatric Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pediatric Diabetes Management Market: Regional Estimates & Trend Analysis by Product, Technology, End-Use

  • 7.1. Regional Outlook
  • 7.2. Pediatric Diabetes Management Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Dexcom
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Abbott
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Tandem Diabetes Care
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Insulet Corporation
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Novo Nordisk
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Sanofi
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Eli Lilly and Company
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Roche Diabetes Care
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Ascensia Diabetes Care
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives